小胶质细胞在脑出血病理生理学机制中的研究进展

doi:10.3969/j.issn.1672-6731.2021.02.003

摘要/Abstract

摘要：

脑出血是临床常见的脑血管病之一，目前尚缺乏有效治疗药物。小胶质细胞是一种特异性存在于中枢神经系统的免疫细胞，脑出血急性期小胶质细胞迅速激活并在M1型与M2型之间动态转变，提示小胶质细胞在脑出血后继发性神经炎症反应的病理生理学过程中具有复杂的作用机制，成为探究脑出血治疗药物的重要靶点。本文对脑出血后小胶质细胞表面标志物、极化表型、血肿清除机制及其与神经元、星形胶质细胞和少突胶质细胞之间的潜在联系进行综述，旨在探究通过调控小胶质细胞功能治疗脑出血的可能性。

关键词: 脑出血, 小神经胶质细胞, 炎症趋化因子类, 综述

Abstract:

Intracranial hemorrhage (ICH) is one of the most common cerebrovascular disease. At present, there is still a lack of drugs with definite curative effects for the treatment of intracranial hemorrhage. Microglia is a type of immune cell that specifically exists in the central nervous system. In the acute phase of intracranial hemorrhage, microglia is rapidly activated and can dynamically transform between M1 phenotype (pro-inflammatory) and M2 phenotype (repair). These two different polarization states suggest that microglia plays a complicated role in the pathophysiological process of secondary neuroinflammation after intracranial hemorrhage. Therefore, this is also an important target for exploring drugs for the treatment of intracranial hemorrhage. This article reviews the surface markers of microglia after intracranial hemorrhage, polarization phenotype, phagocytic hematoma, and potential connections with neurons, astrocytes, and oligodendrocytes, in order to find the possibility of treating intracranial hemorrhage by regulating the function of microglia.

Key words: Cerebral hemorrhage, Microglia, Chemokines, Review

符巍, 马潞, 谭赢, 游潮. 小胶质细胞在脑出血病理生理学机制中的研究进展[J]. 中国现代神经疾病杂志, 2021, 21(2): 76-81.

FU Wei, MA Lu, TAN Ying, YOU Chao. Research progress of microglia in the pathophysiological mechanism of intracranial hemorrhage[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(2): 76-81.

http://journal11.magtechjournal.com/cjcnn/CN/Y2021/V21/I2/76

参考文献

[1] Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, Forsting M, Harnof S, Klijn CJ, Krieger D, Mendelow AD, Molina C, Montaner J, Overgaard K, Petersson J, Roine RO, Schmutzhard E, Schwerdtfeger K, Stapf C, Tatlisumak T, Thomas BM, Toni D, Unterberg A, Wagner M; European Stroke Organisation. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage[J]. Int J Stroke, 2014, 9:840-855.
[2] Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010(GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010[J]. Lancet, 2014, 383:245-254.
[3] van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin:a systematic review and meta-analysis[J]. Lancet Neurol, 2010, 9:167-176.
[4] Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage:systematic review and meta-analysis[J]. J Neurol Neurosurg Psychiatry, 2014, 85:660-667.
[5] Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets[J]. J Stroke, 2020, 22:29-46.
[6] Yang Z, Zhao T, Zou Y, Zhang JH, Feng H. Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage[J]. Immunol Lett, 2014, 160:89-95.
[7] Zhang Z, Zhang Z, Lu H, Yang Q, Wu H, Wang J. Microglial polarization and inflammatory mediators after intracerebral hemorrhage[J]. Mol Neurobiol, 2017, 54:1874-1886.
[8] Wang J, Yu L, Jiang C, Chen M, Ou C, Wang J. Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis[J]. Brain Behav Immun, 2013, 34:56-66.
[9] Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM; STICH Ⅱ Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH Ⅱ):a randomised trial[J]. Lancet, 2013, 382:397-408.
[10] Mosser CA, Baptista S, Arnoux I, Audinat E. Microglia in CNS development:shaping the brain for the future[J]. Prog Neurobiol, 2017, 149/150:1-20.
[11] Wang G, Shi Y, Jiang X, Leak RK, Hu X, Wu Y, Pu H, Li WW, Tang B, Wang Y, Gao Y, Zheng P, Bennett MV, Chen J. HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis[J]. Proc Natl Acad Sci USA, 2015, 112:2853-2858.
[12] Casella G, Garzetti L, Gatta AT, Finardi A, Maiorino C, Ruffini F, Martino G, Muzio L, Furlan R. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo[J]. J Neuroinflammation, 2016, 13:139.
[13] Kim CC, Nakamura MC, Hsieh CL. Brain trauma elicits non-canonical macrophage activation states[J]. J Neuroinflammation, 2016, 13:117.
[14] Ransohoff RM. A polarizing question:do M1 and M2 microglia exist[J]? Nat Neurosci, 2016, 19:987-991.
[15] Kiguchi N, Kobayashi D, Saika F, Matsuzaki S, Kishioka S. Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury[J]. J Neuroinflammation, 2018, 15:96.
[16] Zeiner PS, Preusse C, Golebiewska A, Zinke J, Iriondo A, Muller A, Kaoma T, Filipski K, Müller-Eschner M, Bernatz S, Blank AE, Baumgarten P, Ilina E, Grote A, Hansmann ML, Verhoff MA, Franz K, Feuerhake F, Steinbach JP, Wischhusen J, Stenzel W, Niclou SP, Harter PN, Mittelbronn M. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas[J]. Brain Pathol, 2019, 29:513-529.
[17] Mathews S, Branch Woods A, Katano I, Makarov E, Thomas MB, Gendelman HE, Poluektova LY, Ito M, Gorantla S. Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice[J]. Mol Neurodegener, 2019, 14:12.
[18] O'Neil SM, Witcher KG, McKim DB, Godbout JP. Forced turnover of aged microglia induces an intermediate phenotype but does not rebalance CNS environmental cues driving priming to immune challenge[J]. Acta Neuropathol Commun, 2018, 6:129.
[19] Rangaraju S, Raza SA, Li NX, Betarbet R, Dammer EB, Duong D, Lah JJ, Seyfried NT, Levey AI. Differential phagocytic properties of CD45^low microglia and CD45^high brain mononuclear phagocytes-activation and age-related effects[J]. Front Immunol, 2018, 9:405.
[20] Martin E, El-Behi M, Fontaine B, Delarasse C. Analysis of microglia and monocyte-derived macrophages from the central nervous system by flow cytometry[J]. J Vis Exp, 2017:55781.
[21] Liu DL, Zhao LX, Zhang S, Du JR. Peroxiredoxin 1-mediated activation of TLR4/NF-κB pathway contributes to neuroinflammatory injury in intracerebral hemorrhage[J]. Int Immunopharmacol, 2016, 41:82-89.
[22] Liew HK, Pang CY, Hsu CW, Wang MJ, Li TY, Peng HF, Kuo JS, Wang JY. Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats[J]. J Neuroinflammation, 2012, 9:13.
[23] Lei B, Dawson HN, Roulhac-Wilson B, Wang H, Laskowitz DT, James ML. Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage[J]. J Neuroinflammation, 2013, 10:103.
[24] Zhao H, Garton T, Keep RF, Hua Y, Xi G. Microglia/Macrophage polarization after experimental intracerebral hemorrhage[J]. Transl Stroke Res, 2015, 6:407-409.
[25] Taylor RA, Chang CF, Goods BA, Hammond MD, Mac Grory B, Ai Y, Steinschneider AF, Renfroe SC, Askenase MH, McCullough LD, Kasner SE, Mullen MT, Hafler DA, Love JC, Sansing LH. TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage[J]. J Clin Invest, 2017, 127:280-292.
[26] Kerr N, Dietrich DW, Bramlett HM, Raval AP. Sexually dimorphic microglia and ischemic stroke[J]. CNS Neurosci Ther, 2019, 25:1308-1317.
[27] Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology[J]. Trends Mol Med, 2019, 25:112-123.
[28] Hiragi T, Ikegaya Y, Koyama R. Microglia after seizures and in epilepsy[J]. Cells, 2018, 7:26.
[29] Avdic S, McSharry BP, Steain M, Poole E, Sinclair J, Abendroth A, Slobedman B. Human cytomegalovirus-encoded human interleukin-10(IL-10) homolog amplifies its immunomodulatory potential by upregulating human IL-10 in monocytes[J]. J Virol, 2016, 90:3819-3827.
[30] Song L, Xu LF, Pu ZX, Wang HH. IL-10 inhibits apoptosis in brain tissue around the hematoma after ICH by inhibiting proNGF[J]. Eur Rev Med Pharmacol Sci, 2019, 23:3005-3011.
[31] Gris T, Laplante P, Thebault P, Cayrol R, Najjar A, Joannette-Pilon B, Brillant-Marquis F, Magro E, English SW, Lapointe R, Bojanowski M, Francoeur CL, Cailhier JF; Canadian Critical Care Translational Biology Group. Innate immunity activation in the early brain injury period following subarachnoid hemorrhage[J]. J Neuroinflammation, 2019, 16:253.
[32] Zhou K, Zhong Q, Wang YC, Xiong XY, Meng ZY, Zhao T, Zhu WY, Liao MF, Wu LR, Yang YR, Liu J, Duan CM, Li J, Gong QW, Liu L, Yang MH, Xiong A, Wang J, Yang QW. Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia/macrophage polarization through the IL-10/GSK3β/PTEN axis[J]. J Cereb Blood Flow Metab, 2017, 37:967-979.
[33] Wan S, Cheng Y, Jin H, Guo D, Hua Y, Keep RF, Xi G. Microglia activation and polarization after intracerebral hemorrhage in mice:the role of protease-activated receptor-1[J]. Transl Stroke Res, 2016, 7:478-487.
[34] Wang M, Cheng L, Chen ZL, Mungur R, Xu SH, Wu J, Liu XL, Wan S. Hyperbaric oxygen preconditioning attenuates brain injury after intracerebral hemorrhage by regulating microglia polarization in rats[J]. CNS Neurosci Ther, 2019, 25:1126-1133.
[35] Lan X, Han X, Li Q, Yang QW, Wang J. Modulators of microglial activation and polarization after intracerebral haemorrhage[J]. Nat Rev Neurol, 2017, 13:420-433.
[36] Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer's disease[J]. J Cell Biol, 2018, 217:459-472.
[37] Wang Y, Chen Q, Tan Q, Feng Z, He Z, Tang J, Feng H, Zhu G, Chen Z. Simvastatin accelerates hematoma resolution after intracerebral hemorrhage in a PPARγ-dependent manner[J]. Neuropharmacology, 2018, 128:244-254.
[38] Fang H, Chen J, Lin S, Wang P, Wang Y, Xiong X, Yang Q. CD36- mediated hematoma absorption following intracerebral hemorrhage:negative regulation by TLR4 signaling[J]. J Immunol, 2014, 192:5984-5992.
[39] Ni W, Mao S, Xi G, Keep RF, Hua Y. Role of erythrocyte CD47 in intracerebral hematoma clearance[J]. Stroke, 2016, 47:505-511.
[40] Wang G, Li T, Duan SN, Dong L, Sun XG, Xue F. PPAR-γ promotes hematoma clearance through haptoglobin-hemoglobin-CD163 in a rat model of intracerebral hemorrhage[J]. Behav Neurol, 2018:ID7646104.
[41] Liu R, Cao S, Hua Y, Keep RF, Huang Y, Xi G. CD163 expression in neurons after experimental intracerebral hemorrhage[J]. Stroke, 2017, 48:1369-1375.
[42] Mecca C, Giambanco I, Donato R, Arcuri C. Microglia and aging:the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes[J]. Int J Mol Sci, 2018, 19:318.
[43] Zhang Y, Zhao L, Wang X, Ma W, Lazere A, Qian HH, Zhang J, Abu-Asab M, Fariss RN, Roger JE, Wong WT. Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation[J]. Sci Adv, 2018, 4:eaap8492.
[44] Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration[J]. Nat Neurosci, 2018, 21:1359-1369.
[45] Zhao XF, Alam MM, Liao Y, Huang T, Mathur R, Zhu X, Huang Y. Targeting microglia using Cx3cr1-Cre lines:revisiting the specificity[J]. eNeuro, 2019, 6:ENEURO.0114-19.
[46] Yang G, Chen L, Gao Z, Wang Y. Implication of microglia activation and CSF1/CSF1R pathway in lumbar disc degeneration-related back pain[J]. Mol Pain, 2018, 14:1744806918811238.
[47] Sansing LH, Harris TH, Welsh FA, Kasner SE, Hunter CA, Kariko K. Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage[J]. Ann Neurol, 2011, 70:646-656.
[48] Taylor RA, Hammond MD, Ai Y, Sansing LH. CX3CR1 signaling on monocytes is dispensable after intracerebral hemorrhage[J]. PLoS One, 2014, 9:e114472.
[49] Zhang ZJ, Jiang BC, Gao YJ. Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain[J]. Cell Mol Life Sci, 2017, 74:3275-3291.
[50] Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage:from mechanisms to clinical translation[J]. Prog Neurobiol, 2014, 115:25-44.
[51] Guo F, Xu D, Lin Y, Wang G, Wang F, Gao Q, Wei Q, Lei S. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage[J]. FASEB J, 2020, 34:1872-1884.
[52] Yao Y, Tsirka SE. The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage[J]. Glia, 2012, 60:908-918.
[53] Shi SX, Li YJ, Shi K, Wood K, Ducruet AF, Liu Q. IL (Interleukin)-15 bridges astrocyte-microglia crosstalk and exacerbates brain injury following intracerebral hemorrhage[J]. Stroke, 2020, 51:967-974.
[54] Joseph MJ, Caliaperumal J, Schlichter LC. After intracerebral hemorrhage, oligodendrocyte precursors proliferate and differentiate inside white-matter tracts in the rat striatum[J]. Transl Stroke Res, 2016, 7:192-208.
[55] Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM, Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination[J]. Nat Neurosci, 2013, 16:1211-1218.
[56] Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J. Neuroprotective role of haptoglobin after intracerebral hemorrhage[J]. J Neurosci, 2009, 29:15819-15827.

选择文件类型/文献管理软件名称

选择包含的内容

2 小胶质细胞在脑出血病理生理学机制中的研究进展

Research progress of microglia in the pathophysiological mechanism of intracranial hemorrhage

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	薛蓉, 张轩. 睡眠障碍对脑血管病的影响[J]. 中国现代神经疾病杂志, 2023, 23(8): 659-662.
[2]	张鹏, 陈涛, 许莉. 成人失眠认知行为疗法关键技术与流程改进建议[J]. 中国现代神经疾病杂志, 2023, 23(8): 663-667.
[3]	张轩, 薛蓉. 特发性快速眼动睡眠期行为障碍向神经系统变性疾病转化的生物学标志物研究进展[J]. 中国现代神经疾病杂志, 2023, 23(8): 668-673.
[4]	刘引, 汤永红, 翟锦霞, 邱媛. 慢性低度炎症与睡眠障碍研究进展[J]. 中国现代神经疾病杂志, 2023, 23(8): 674-677.
[5]	于洁洋, 张亚男, 李惠敏, 黄真灿, 李宛儒, 王赞. 发作性睡病与焦虑研究进展[J]. 中国现代神经疾病杂志, 2023, 23(8): 678-682.
[6]	库成心, 邓丽影, 谢亮. 缺血性卒中继发日间过度思睡研究进展[J]. 中国现代神经疾病杂志, 2023, 23(8): 683-686.
[7]	姜佳凤, 赵莲花, 赵伟. 褪黑素在阿尔茨海默病病理损害机制中的作用[J]. 中国现代神经疾病杂志, 2023, 23(8): 687-692.
[8]	黄沛, 王刚. 功能性帕金森综合征诊断与治疗[J]. 中国现代神经疾病杂志, 2023, 23(8): 738-741.
[9]	洪涛, 唐斌. 如何成为一名优秀的颅底外科医师[J]. 中国现代神经疾病杂志, 2023, 23(7): 571-574.
[10]	张庆硕, 宋丹丹, 周世越, 张金璐, 韩晓旭, 许顺良. 功能性步态障碍诊断与治疗[J]. 中国现代神经疾病杂志, 2023, 23(7): 604-609.
[11]	潘希娟, 邢英琦, 刘玉梅. 脑小血管病影像学评分方法[J]. 中国现代神经疾病杂志, 2023, 23(7): 633-637.
[12]	俞淑凤, 李宁, 徐健, 王鹏. 颈动脉漂浮血栓相关缺血性卒中诊断与治疗进展[J]. 中国现代神经疾病杂志, 2023, 23(7): 638-642.
[13]	魏俊吉. 神经外科重症医学规范化诊断与治疗[J]. 中国现代神经疾病杂志, 2023, 23(6): 477-478.
[14]	杜倩, 邓素君, 邹姗, 金珺, 周青山. 宏基因组第二代测序技术在重症中枢神经系统感染中的应用[J]. 中国现代神经疾病杂志, 2023, 23(6): 479-484.
[15]	曲鑫, 赵浩, 尚峰, 王宁. 神经重症目标温度管理[J]. 中国现代神经疾病杂志, 2023, 23(6): 485-489.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 小胶质细胞在脑出血病理生理学机制中的研究进展

Research progress of microglia in the pathophysiological mechanism of intracranial hemorrhage

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价